TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
5.48
+0.08 (1.48%)
Aug 19, 2026, 12:31 PM EDT - Market open
TriSalus Life Sciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 46.29 | 20.44 | 8.53 | 11.78 | 9.41 | 30.3 |
Cash & Short-Term Investments | 46.29 | 20.44 | 8.53 | 11.78 | 9.41 | 30.3 |
Cash Growth | 74.74% | 139.75% | -27.61% | 25.10% | -68.93% | 575.16% |
Receivables | 6.46 | 6.56 | 5.09 | 3.55 | 1.56 | 1.36 |
Inventory | 4.21 | 3.08 | 4.05 | 2.55 | 1.47 | 1.29 |
Prepaid Expenses | 2.79 | 2.17 | 3.01 | 2.99 | 4.77 | 2.18 |
Total Current Assets | 59.74 | 32.24 | 20.67 | 20.86 | 17.21 | 35.13 |
Property, Plant & Equipment | 2.64 | 2.67 | 2.88 | 3.27 | 3.61 | 1.8 |
Other Intangible Assets | - | - | - | - | 0.8 | 0.79 |
Other Long-Term Assets | 0.07 | 0.42 | 0.42 | 0.47 | 0.37 | 0.12 |
Total Assets | 62.45 | 35.33 | 23.97 | 24.6 | 22 | 37.84 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 3.76 | 3 | 2.27 | 3.39 | 4.95 | 1.3 |
Accrued Expenses | 7.11 | 8 | 7.32 | 10.53 | 6.38 | 4.97 |
Current Portion of Leases | 0.24 | 0.17 | 0.22 | 0.35 | 0.37 | - |
Current Income Taxes Payable | - | 0.1 | 0.03 | 0.03 | - | - |
Other Current Liabilities | 0.06 | 0.23 | 0.38 | 0.39 | 20.66 | 0.1 |
Total Current Liabilities | 11.17 | 11.5 | 10.23 | 14.69 | 32.36 | 6.37 |
Long-Term Debt | 33.07 | 33.05 | 22.08 | - | - | - |
Long-Term Leases | 1.12 | 1.23 | 1.33 | 1.24 | 1.59 | - |
Other Long-Term Liabilities | 10.54 | 23.42 | 16.22 | 35.73 | 0.37 | 0.56 |
Total Liabilities | 55.9 | 69.19 | 49.87 | 51.66 | 34.32 | 6.93 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.01 | 0 | 0 | 0 | - | 0.01 |
Additional Paid-In Capital | 344.78 | 296.72 | 253.65 | 222.44 | 10.03 | 6.73 |
Retained Earnings | -338.23 | -330.58 | -279.55 | -249.5 | -186.36 | -136.34 |
Total Common Equity | 6.55 | -33.86 | -25.89 | -27.07 | -176.33 | -129.6 |
Shareholders' Equity | 6.55 | -33.86 | -25.89 | -27.07 | -12.32 | 30.9 |
Total Liabilities & Equity | 62.45 | 35.33 | 23.97 | 24.6 | 22 | 37.84 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 34.43 | 34.44 | 23.63 | 1.6 | 1.96 | - |
Net Cash (Debt) | 11.86 | -14 | -15.1 | 10.18 | 7.45 | 30.3 |
Net Cash Growth | - | - | - | 36.65% | -75.41% | - |
Net Cash Per Share | 0.24 | -0.37 | -0.60 | 1.08 | 24.07 | 3.42 |
Filing Date Shares Outstanding | 61.57 | 61.31 | 32.27 | 26.76 | 14.08 | 12.96 |
Total Common Shares Outstanding | 61.47 | 50 | 31.28 | 26.41 | 14.08 | 10.72 |
Working Capital | 48.57 | 20.75 | 10.44 | 6.18 | -15.14 | 28.76 |
Book Value Per Share | 0.11 | -0.68 | -0.83 | -1.02 | -12.53 | -12.09 |
Tangible Book Value | 6.55 | -33.86 | -25.89 | -27.07 | -177.13 | -130.4 |
Tangible Book Value Per Share | 0.11 | -0.68 | -0.83 | -1.02 | -12.58 | -12.16 |
Machinery | - | 3.21 | 4.34 | 3.8 | 3.87 | 3.15 |
Construction In Progress | - | 0.25 | 0.33 | 0.6 | - | - |
Leasehold Improvements | - | 1.57 | 0.77 | 0.77 | 0.77 | 0.78 |